摘要 |
<p>A novel drug development target protein and gene, and, using these, means for developing a novel pharmaceutical. In particular, there are provided an NCS protein and a gene therefor; a method of screening a drug (for example, anti-central neurologic disease agent); a regulator of diseases (for example, central neurologic disease); a process for producing drug derivatives; a complex containing a drug and an NCS protein, and a process for producing the same; a kit including a drug or its salt; a method of determining the development or development risk of given disease, a method of determining the sensitivity to drugs, and a determination kit for use in the methods; etc. Further, there is provided a compound, or its salt, capable of binding to NCS proteins, represented by the following formula (I), and provided a therapeutic or preventive agent for dementia comprising the compound of the formula (I) or pharmaceutically acceptable salt thereof as an active ingredient. (wherein R1-R8 represent hydrogen atoms, etc.)</p> |
申请人 |
REVERSE PROTEOMICS RESEARCH INSTITUTE CO., LTD.;YAMAUCHI, TADAKAZU;SUEOKA, HIDEAKI;TSUCHIYA, KOUICHI;MURAYAMA, KATSUHISA;HORIUCHI, KEN;KOMIYA, KAZUO;KITO, MORIKAZU;TSUTSUMI, TAKESHI;ISONO, YUKO;SUWA, YORIMASA |
发明人 |
YAMAUCHI, TADAKAZU;SUEOKA, HIDEAKI;TSUCHIYA, KOUICHI;MURAYAMA, KATSUHISA;HORIUCHI, KEN;KOMIYA, KAZUO;KITO, MORIKAZU;TSUTSUMI, TAKESHI;ISONO, YUKO;SUWA, YORIMASA |